53
Views
5
CrossRef citations to date
0
Altmetric
Letter to the Editor

Hodgkin disease subsequent to follicular lymphoma on maintenance rituximab

, , , , , , , , , & show all
Pages 1878-1880 | Received 03 May 2007, Accepted 12 Jun 2007, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Pasquale Niscola, Massimiliano Palombi, Stefano Fratoni, Malgorzata Monika Trawinska, Laura Scaramucci, Marco Giovannini, Alessio Perrotti & Paolo De Fabritiis. (2009) Unusual sequence of lymphoid disorders: Follicular lymphoma subsequent to Hodgkin lymphoma and transformed into diffuse large B-cells non Hodgkin lymphoma. Acta Oncologica 48:7, pages 1073-1074.
Read now

Articles from other publishers (4)

J. Khristi, U. Mey, J. Kirfel, I. G. H. Schmidt-Wolf & I. Gütgemann. (2013) Sequential Hodgkin’s and non-Hodgkin’s lymphoma in non-immunocompromised patients. Annals of Hematology 92:11, pages 1565-1567.
Crossref
Akiko M. Maeshima, Hirokazu Taniguchi, Suguru Fukuhara, Noriyuki Morikawa, Wataru Munakata, Dai Maruyama, Sung-Won Kim, Takashi Watanabe, Yukio Kobayashi, Kensei Tobinai & Hitoshi Tsuda. (2013) Follow-up Data of 10 Patients With B-cell Non-Hodgkin Lymphoma With a CD20-negative Phenotypic Change After Rituximab-containing Therapy. American Journal of Surgical Pathology 37:4, pages 563-570.
Crossref
Akiko Miyagi Maeshima, Hirokazu Taniguchi, Junko Nomoto, Dai Maruyama, Sung-Won Kim, Takashi Watanabe, Yukio Kobayashi, Kensei Tobinai & Yoshihiro Matsuno. (2009) Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy. Cancer Science 100:1, pages 54-61.
Crossref
. (2008) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 17:5.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.